- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01224379
Comparison of Standard Fusion With "Topping Off"-System in Lumbar Spine (Topping-off)
Clinical Trial of the Efficacy of Hybrid Systems(Topping Off)in Comparison to the Conventional Spondylodesis in Fusion-surgery in the Lumbal Spine: a Prospective, Randomised Study
Study Overview
Status
Intervention / Treatment
Detailed Description
Primary efficacy endpoint:
The baseline and follow-up values after 6 weeks after the operation as well as 6 and 12 months after baseline of the SF-36 (Short-Form-36)-Measured Outcome regarding the Physical Component Summary (PCS).
Key secondary endpoint(s):
- Mental Component Summary (MCS) and individual dimensions and subscales of the SF-36
- Individual dimensions of the Oswestry Disability Index (ODI)
- Time until radiological adjacent instability and comparison to the clinical outcome
- Capacity of work at the time of surgery and after surgery, time until return to work
Assessment of safety:
- Treatment complication in control and intervention groups (SAE-management)
- A rating committee will provide consistency of the procedure and the assessment of data (e.g. by intraoperative photos, surgery reports, x-rays) to minimize bias
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jan Siewe, Dr.
- Phone Number: +49-221-478-87294
- Email: studienzentrum-ortho-unfall@uk-koeln.de
Study Contact Backup
- Name: Margarete Wicharz
- Phone Number: +49-221-478-87294
- Email: studienzentrum-ortho-unfall@uk-koeln.de
Study Locations
-
-
-
Cologne, Germany, 50931
- University of Cologne, Department of Orthopedics& traumasurgery
-
Contact:
- Jan Siewe, Dr.
- Phone Number: +49-221-478-87294
- Email: studienzentrum-ortho-unfall@uk-koeln.de
-
Principal Investigator:
- Jan Siewe, Dr.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Key inclusion criteria:
- Male or female >30 years of age
- Lumbar spine pathology with indication for monosegmental PLIF
- Radiological signs of a degeneration of the adjacent segment without instability
Key exclusion criteria:
1. Radiological signs of existing instability of the adjacent segment 2. Normal endplates and no disc desiccation in MRI in the adjacent seg-ment 3. Previous surgery of the lumbar spine
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Arm1: "topping off" system
The intervention group will receive a "topping off" system (PLIF -posterior intervertebral fusion- connected with a flexible pedicle screw system above the fusion).
|
The intervention group will receive a "topping off" system (PLIF -posterior intervertebral fusion- connected with a flexible pedicle screw system above the fusion).
Other Names:
|
Other: Arm 2: monosegmental PLIF
The control group receives a monosegmental PLIF.
This is the current standard therapy for many pathologies in the lumbar spine (e.g.
Spondylolisthesis)
|
The control group receives a monosegmental PLIF.
This is the current standard therapy for many pathologies in the lumbar spine (e.g.
Spondylolisthesis)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SF36
Time Frame: 6 Month
|
Primary efficacy endpoint: The baseline and follow-up values after 6 weeks after the operation as well as 6 and 12 months after baseline of the SF-36 (Short-Form-36)-Measured Outcome regarding the Physical Component Summary (PCS). |
6 Month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
1.Mental Component Summary (MCS) and individual dimensions and subscales of the Mental Component Summary (MCS) and individual dimensions and subscales of SF-36
Time Frame: 6 weeks
|
1. Mental Component Summary (MCS) and individual dimensions and subscales of the SF-36 follow-up values after 6 weeks after the operation as well as 6 and 12 months after baseline
|
6 weeks
|
Safety
Time Frame: all time
|
Assessment of safety:
|
all time
|
Individual dimensions of the Oswestry Disability Index (ODI)
Time Frame: 6weeks
|
Individual dimensions of the Oswestry Disability Index (ODI) follow-up values after 6 weeks after the operation as well as 6 and 12 months after baseline
|
6weeks
|
Time until radiological adjacent instability and comparison to the clinical outcome
Time Frame: 6 weeks
|
Time until radiological adjacent instability and comparison to the clinical outcome follow-up values after 6 weeks after the operation as well as 6 and 12 months after baseline
|
6 weeks
|
Capacity of work at the time of surgery and after surgery, time until return to work
Time Frame: 6 weeks
|
Capacity of work at the time of surgery and after surgery, time until return to work follow-up values after 6 weeks after the operation as well as 6 and 12 months after baseline
|
6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jan Siewe, Dr., University of Cologne
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Uni-Köln-1223 (Other Grant/Funding Number: University of Cologne)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spondylolisthesis
-
Jos M. A. KuijlenNot yet recruitingDegenerative Spondylolisthesis | Spondylolytic Spondylolisthesis
-
Lahey ClinicDePuy SynthesActive, not recruitingLumbar Spondylolisthesis | Lumbar Spondylosis | Degenerative SpondylolisthesisUnited States
-
Lahey ClinicTerminatedLumbar Spinal Stenosis | Lumbar Spondylolisthesis | Degenerative Spondylolisthesis | Grade 1 SpondylolisthesisUnited States, Canada
-
Jyväskylä Central HospitalTampere University; Tampere University HospitalCompletedSpondylolisthesis, Degenerative | Spondylolisthesis, IsthmicFinland
-
Assistance Publique - Hôpitaux de ParisRecruitingSpondylolisthesis, Lumbar RegionFrance
-
Haukeland University HospitalActive, not recruitingDegenerative Lumbar SpondylolisthesisNorway
-
The London Spine CentreUnknownDegenerative Lumbar SpondylolisthesisCanada
-
Andrew GlennieUnknownSpondylolisthesis, Lumbar Region
-
Assiut UniversityNot yet recruitingLumbar Spondylolisthesis
-
AOSpine North America Research NetworkCompletedIsthmic SpondylolisthesisUnited States, Canada
Clinical Trials on Topping off system
-
University of British ColumbiaNot yet recruitingPersistent Developmental Stutter | Childhood-Onset Fluency Disorder (Stuttering)
-
ReShape LifesciencesCompletedObesityUnited States, Australia
-
Restor3DTerminatedOsteoarthritis, KneeUnited States
-
Restor3DCompletedOsteoarthritisUnited States, Germany
-
Karolinska InstitutetThe Swedish Research CouncilCompletedOrthopaedic Surgery (30 Minutes or Longer)Sweden
-
Shalamar Institute of Health SciencesRecruitingPost Partum Lumbopelvic PainPakistan
-
University of North Carolina, Chapel HillAcademy of Nutrition and DieteticsRecruitingObesity | Overweight | Overweight and ObesityUnited States
-
Friends Research Institute, Inc.National Institute on Drug Abuse (NIDA)Active, not recruitingHIV/AIDS | Methamphetamine AbuseUnited States